
	Where results make sense

Topic: Glaxo

Related Topics

CODASYL

Tesco

Indie rock

Hornbeak, Tennessee

Passport

Chore

Aquifer

NQR

Holsworthy

Analingus

Caprice Bourret

Stella McCartney

Nathan Mayer Rothschild

Leeds

Kefir

In the News (Fri 25 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	HIV & AIDS - Glaxo behind citizen lobby effort
		The group was financed by Glaxo Wellcome, one of the drug companies that commands a large part of the $761 million-a-year inhaler market and is lagging behind a competitor in the race to produce new, ozone-friendly inhalers.
		Glaxo said it underwrote the committee's efforts as part of a broader lobbying campaign aimed at making sure a full range of drugs remains available to people with breathing problems.
		Glaxo's Serevent and Ventolin inhalers command 44 percent of the market for aerosol drugs that dilate the airways leading to the lungs.
	www.virusmyth.net /aids/news/apglaxolobby.htm (635 words)

	Fool.com: Depressing Year for Glaxo [Motley Fool Take] February 12, 2004
		Glaxo sees the first three quarters of 2004 to be a study in the blues.
		Glaxo highlighted several drugs that are approaching hoped-for approval and subsequent launch, including solifenacin succinate, a treatment for a bladder disorder that affects 17 million people in the U.S., as well as Epivir/Ziagen, touted as the first once-daily combination HIV/AIDS treatment in a single tablet.
		Glaxo sweetened the deal with the promise of a dividend hike, though by only about 1%, the same amount as last year.
	www.fool.com /News/mft/2004/mft04021218.htm (502 words)

	Project Inform TAN Action Alert - June 24, 1997 ( HIV / AIDS Treatment Information )
		Urge Glaxo to increase its compassionate use program for 1592 to meet the need of all who are qualified, and to accelerate their plans for submitting data for an FDA approval.
		Glaxo Wellcome’s 1592 is a nucleoside analogue drug (similar to AZT) that has recently raised great interest in the AIDS community.
		Glaxo Wellcome’s currently plans to file for FDA approval in possible, for those people who have exhausted current therapies and lack sufficient elements for an effective combination therapy strategy.
	www.projectinform.org /news/97_07alert.html (947 words)

	Analyst Meet (Site not responding. Last check: 2007-10-30)
		Glaxo India- one of the oldest pharma houses in India witnessed a moderate sales growth of 9%, which was around the industry growth rate in F12/99.
		Glaxo India after a quite start in the Q1FY00, announced a topline growth of 27% and a bottomline growth of 103% for the second quarter of the FY00.
		Glaxo India, Wellcome and Biddle Sawyer (subsidiaries) are growing at a faster rate as compared to industry growth of 10% in FY2000.
	www.indiainfoline.com /meet/me235.html (1579 words)

	Bloomberg.com: U.K.
		Glaxo and AstraZeneca, both based in London, had setbacks with regulators and experimental treatments and lost patent protection on best-selling products, making their ability to use advertising to boost sales of older products more important, analysts said.
		Glaxo's net income rose to 1.20 billion pounds ($2.29 billion), or 21 pence a share, from 1.04 billion pounds, or 18 pence, in the year-earlier period.
		Glaxo is relying on Advair and its diabetes medicine Avandia, which is an ingredient in Avandamet, to bolster profit after its former top-seller, Paxil, which includes Paxil CR and the shorter- acting Paxil IR, lost sales to generic rivals.
	www.bloomberg.com /apps/news?pid=10000102&sid=amoZcW6BU5_k&refer=uk (853 words)

	Concern over Glaxo Wellcome discontinuations
		If a company with the resources of Glaxo Wellcome is unwilling to seek to license products used in children for which there is overwhelming evidence of efficacy in large numbers of patients, there seems to be little hope that other suppliers will seek to license their products.
		Glaxo Wellcome has created an internal paediatric strategy function, the focus of which is to ensure paediatric strategy is developed early in the drug development life cycle
		Glaxo Wellcome remains committed to and will continue to support the important initiative of developing licensed medications for the paediatric population.
	www.pharmj.com /Editorial/20000729/letters/ballantine.html (1512 words)

	Project Inform TAN Action Alert - March 11, 1997 ( HIV / AIDS Treatment Information )
		Glaxo Wellcome is planning to begin a compassionate use program in the next three weeks for children using a liquid formula.
		Glaxo Wellcome is planning to begin a compassionate use program (a process that provides treatments in development free of charge to people who meet certain eligibility requirements) in the next three weeks for children using a liquid formula.
		The message to Glaxo Wellcome must be loud and clear: make this drug available, as soon as possible, for those people who have exhausted current therapies and lack sufficient elements for an effective combination therapy strategy.
	www.projinf.org /news/97_03alert1592.html (972 words)

	Oceanix Biosciences: Research Agreement with Glaxo Wellcome
		The RSMDB is a content database relating interactions between information-rich chemical compounds and disease-related molecular targets with known biological activities of the compounds.
		Glaxo Wellcome Inc., based in Research Triangle Park, NC, is one of the nation's leading research-based pharmaceutical firms.
		A subsidiary of London-based Glaxo Wellcome plc, the company is committed to fighting disease by bringing innovative medicines and services to patients and to the healthcare providers who serve them.
	www.cfonews.com /anyc/d020800z.txt.html (756 words)

	Pharmaceutical Technology - Glaxo Wellcome Suzhou Anti Infective Drugs Plant - China
		Glaxo Wellcome is investing in new production facilities in Suzhou in the eastern Chinese province of Jiangsu.
		Glaxo hopes that a comprehensive system of patent recognition and respect for intellectual property rights is slowly emerging.
		Glaxo was encouraged by the establishment of a legal framework to enforce the rights of patent holders and further heartened by a direct commitment given to the company by the Chinese government.
	www.pharmaceutical-technology.com /projects/suzhou (616 words)

	SocietyGuardian.co.uk \| Society \| Glaxo 'played down Seroxat side effects'
		Glaxo says that Seroxat does not cause dependence because patients do not crave the drug or need increasing doses to feel good as they would if they were addicted to heroin.
		He said that the patient information leaflet supplied with the drug and approved by the MCA said that "these tablets are not addictive" and that withdrawal problems "are not common and are not a sign of addiction".
		Glaxo said that it was disappointed with the result of the case and that it strives for the highest standards of accuracy.
	society.guardian.co.uk /mentalhealth/story/0,8150,810571,00.html.%20 (493 words)

	Analyst Meet (Site not responding. Last check: 2007-10-30)
		Glaxo, along with Burroughs Wellcome and Biddle Swayer Group of companies, is the market leader in the pharmaceutical sector.
		Glaxo’s initiative in rural/ direct marketing is showing satisfactory results with average turnover of Rs30mn per month.
		Glaxo is increasing its field strength from 1,300 MRs at present to 1,750 in the next one year in order to have better market penetration in the new.
	www.indiainfoline.com /meet/me138.html (973 words)

	AEGiS-WSJ: Glaxo Attempts to Block Access To Generic AIDS Drugs in Ghana
		He says: "If [Glaxo officials] went to court they would lose." A Glaxo spokesman in London says the drug maker believes its drug is patent-protected in Ghana but declined to provide an explanation or legal documentation.
		Glaxo has offered to sell Combivir in Senegal and Uganda for $2 a day, far less than the drug sells for in the U.S. The company said it has offered the same discount to Ghana.
		In particular, Glaxo is believed to be worried that if a small country such as Ghana violates patent protection, that could open a Pandora's box of violations in larger markets, such as South Africa, Latin America and parts of southeast Asia where AIDS is also raging.
	www.aegis.com /news/wsj/2000/WJ001202.html (1231 words)

	domain-B : Indian business : companies : Glaxo Wellcome : What ails Glaxo?
		Glaxo’s aim to become a leading innovator of new medicines and molecules is, indeed, very laudable.
		Glaxo’s previous performance was based on a very sound commercial model that saw it adopt a two-pronged strategy to reformulate old drugs and introduce new drugs.
		Glaxo’s trouble seems to have begun when it only focussed on meeting the needs of the medical fraternity through innovation and new drug discoveries.
	www.domain-b.com /companies/companies_g/glaxo_wellcome/20001205_glaxo_ails.html (765 words)

	icLiverpool - Copycat drugs hitting Glaxo (Site not responding. Last check: 2007-10-30)
		Glaxo said copycat launches caused sales of Paxil to fall 40pc in the final quarter of 2003 while demand declined for another antidepressant Wellbutrin.
		Glaxo said turnover for the year to December 31 grew 1pc to £21.44bn with positive contributions from its core divisions of pharmaceuticals and consumer healthcare, which includes sports drink Lucozade and Sensodyne toothpaste.
		Glaxo is raising its total dividend by 1p to 41p and forecast a similar increase in payments for the current year.
	icliverpool.icnetwork.co.uk /business/news/content_objectid=13946100_method=full_siteid=50061_headline=-Copycat-drugs-hitting-Glaxo-name_page.html (380 words)

	Bloomberg.com: U.K.
		Glaxo proposed a package of about $18 million, saying the 55-year-old CEO should be paid similar to his U.S. rivals.
		Glaxo needs to pay its executives at rates that are competitive with U.S. rivals to prevent other companies from stealing workers, Garnier and Hogg said.
		Glaxo can terminate the contract on two years notice, and will owe him his lump-sum salary and bonus for the two years within 30 days.
	www.snipurl.com /1e7j (614 words)

	Business Report - Glaxo opens new wing in Cape Town
		Glaxo's role was to donate its anti-parasitic drug, albendazole, and help with planning, training and communication initiatives.
		"Glaxo has provided 240 million albendazole treatments free of charge, and with the new facility expects to supply 6 billion tablets to lymphatic filariasis sufferers in 80 countries around the world by 2020," she said.
		Glaxo had spent about $20 million (R130 million) to date on the programme, had donated tablets valued at $48 million, and had made grants of $7 million to the Lymphatic Filariasis Alliance.
	www.busrep.co.za /index.php?fSectionId=&fArticleId=2258767 (712 words)

	SmithKline/Glaxo Merger
		Glaxo investors will swap their shares on a one-for-one basis and will own 58.75 percent of the combined company.
		Glaxo and SmithKline said their combination would generate annual cost savings of 1 billion pounds after the third year, of which 25 percent will be reinvested in research and development.
		Animosity between Leschly and Glaxo executive chairman Richard Sykes was the main hurdle to an earlier pact.
	www.islet.org /forum016/messages/11922.htm (936 words)

	Glaxo to withdraw Lotronex from the U.S. market
		Glaxo Wellcome took this step after in-depth discussions with the U.S. Food and Drug Administration about gastrointestinal side effects that occurred in association with the use of Lotronex.
		Glaxo Wellcome has proposed a range of elements that the company believed would adequately and effectively address these risks.
		Palmer said that Glaxo Wellcome takes a different view from FDA on the ability to educate physicians and patients about the management of potential side effects and benefits of Lotronex.
	www.healthboards.com /irritable-bowel-syndrome/3844.html (970 words)

	Glaxo, Bayer plan challenge to Viagra - Pittsburgh Tribune-Review
		Glaxo, of Brentford, England, and Bayer, of Leverkusen, Germany, are looking to Levitra as they face generic competition to some of their biggest products.
		Glaxo also is awaiting approval of Ariflo, a respiratory treatment that Lehman Brothers estimates may generate sales of $360 million.
		Glaxo's second-quarter net income rose 13 percent to 1.3 billion pounds ($1.5 billion) as the company kept costs down.
	www.pittsburghlive.com /x/tribune-review/business/s_150537.html (688 words)

	Glaxo eases threat -- for now --
		Glaxo eases threat -- for now -- to keep drugs from those that sell to U.S. WINNIPEG (CP) -- Canadian pharmacies have received a stay of execution but not a pardon from a leading drug manufacturer that wants to shut off the flow of cheap prescriptions to the United States.
		Glaxo products represent perhaps 10 per cent of the dollar value of the cross-border trade, but the fear is if Glaxo succeeds, other manufacturers will take similar action.
		Glaxo's latest move also means a legal challenge being planned by Manitoba's Internet pharmacies is on hold, said Kris Thorkelson, a spokesman for the group.
	www.islet.org /forum028/messages/25289.htm (781 words)

	AEGiS-AP: Glaxo Facing Some Product Problems
		Glaxo lost a competition with Roche Pharmaceuticals this year in a battle over new flu drugs- despite Glaxo's heavy marketing blitz that featured "Seinfeld" star Wayne Knight.
		Glaxo has faced hurdles before, perhaps the biggest overcoming the patent expiration in 1997 for its blockbuster ulcer drug Zantac.
		Glaxo is awaiting U.S. approval for Advair, a new drug that combines the company's two asthma drugs Serevent and Flovent.
	www.aegis.com /news/ap/2000/AP000701.html (1026 words)

	1997 June 24 - AIDS Activists Take Over And Hold New York Office Of AIDS Profiteer Glaxo-Wellcome (Site not responding. Last check: 2007-10-30)
		Glaxo has announced that it will begin a compassionate use program in July for abacavir, but that the drug will only be offered to 2,500 people worldwide.
		Glaxo Wellcome has been aggressive about AIDS drug development since the early days of the epidemic, but activists charge that the company has simultaneously been price gouging for years.
		"Glaxo's slow development of abacavir is due the company's desire to squeeze the very last profit dollars out of its cash cows AZT and Epivir until their patents run out," said Bill Bahlman of ACT UP/New York.
	www.hsph.harvard.edu /Organizations/healthnet/HIV/docs/scimed02/SciMed01369.html (657 words)

	Glaxo protects Paxil patent, thwarting generic rivals - Pittsburgh Tribune-Review
		Glaxo is trying to protect its top product from lawsuits filed by closely held Canadian competitor Apotex Inc. Glaxo still expects earnings per share growth of high single digits next year, spokeswoman Siobhan Lavelle said after the pretrial ruling in the U.S. District Court in Philadelphia.
		Glaxo said it will seek an "immediate appeal" of those aspects of the ruling that went against it.
		Glaxo and Apotex are fighting over that patent in a lawsuit in U.S. District Court in Chicago.
	www.pittsburghlive.com /x/tribune-review/business/s_110348.html (490 words)

	Merger of SmithKline Beecham And Glaxo Wellcome
		Until April of this year, Glaxo had been in the final stages of seeking FDA approval to market Zovirex in the United States, but withdrew its application this past spring, several months after its proposed merger with SB was announced.
		Glaxo, while relatively new to the vaccine development arena, has a significant effort under way to develop a vaccine to prevent the contraction of genital herpes.
		Glaxo, through a collaboration with Gilead Sciences, is developing a drug that would treat ovarian, breast, non-small cell lung and other solid tumors, including colorectal cancer, in direct competition with SB's Hycamptin.
	www.ftc.gov /opa/2000/12/skb.htm (2297 words)

	USATODAY.com - Canadian pharmacy calls for boycott of Glaxo (Site not responding. Last check: 2007-10-30)
		Glaxo says it is concerned that Internet sales and shipping efforts could lead to patient safety problems.
		Glaxo's Patty Seif says the company is "sorry to hear that seniors are being encouraged to decide on the brand of their over-the-counter medicines in response to concerns over this issue." Glaxo's priority remains safety, she says.
		Glaxo, whose U.S. sales were $15.4 billion in 2001, sells a number of commonly prescribed drugs, including Flovent for asthma and Paxil for depression.
	www.usatoday.com /money/industries/health/drugs/2003-02-04-canada-glaxo_x.htm (471 words)

	Glaxo Pulls Antibiotic Raxar Linked to Seven Deaths in Europe (Site not responding. Last check: 2007-10-30)
		Glaxo is withdrawing the drug immediately from the 36 countries where it is prescribed, the company said.
		Glaxo’s decision surprised the U.S. Food and Drug Administration, which said Wednesday it had not yet decided whether the drug was too risky to continue selling to Americans.
		Glaxo earned $17 million in Raxar sales last year, compared to $1.25 billion from its anti-ulcer drug, Zantac.
	www.whale.to /drugs/raxar.html (437 words)

	Guardian Unlimited \| Special reports \| Glaxo cure-all goes down badly
		Chief executive Jean-Pierre Garnier argued that Glaxo has a "good chance" in the years 2006-08 of being the fastest growing of the world's big pharmaceutical companies.
		Tachi Yamada, Glaxo's head of research and development, admitted that development of the drug has been delayed by about eight months but said the firm still plans to file for regulatory approval in 2005.
		Cervical cancer Glaxo's vaccine appears to be 100% effective in preventing infection by the papillomaviruses with the highest risk of cervical cancer.
	www.guardian.co.uk /medicine/story/0,11381,1099391,00.html (560 words)

Try your search on: Qwika (all wikis)